Akari Therapeutics Company

Auto-immune diseases. Develop life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.
Technology: AgeTech Companies
Industry: Healthcare
Headquarters: United Kingdom
Founded Date: 2005
Employees Number: 11-50
Funding Status: IPO
Estimated Revenue: $1M to $10M

Visit Website
N/A@N.A
Register and Claim Ownership